ERGIC1 | Endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ERGIC3 | ERGIC and golgi 3 | Predicted membrane proteins
| | | | | Expressed in all |
ERN1 | Endoplasmic reticulum to nucleus signaling 1 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
FAIM2 | Fas apoptotic inhibitory molecule 2 | Predicted membrane proteins
| | | | | Tissue enriched |
FAM155A | Family with sequence similarity 155, member A | Predicted membrane proteins
| | | | | Tissue enriched |
FMR1NB | Fragile X mental retardation 1 neighbor | Predicted membrane proteins
| | | | | Tissue enriched |
FXYD6 | FXYD domain containing ion transport regulator 6 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
GCLC | Glutamate-cysteine ligase, catalytic subunit | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
GDAP1 | Ganglioside induced differentiation associated protein 1 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
GGT6 | Gamma-glutamyltransferase 6 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
GPM6A | Glycoprotein M6A | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
GPR160 | G protein-coupled receptor 160 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
HAS3 | Hyaluronan synthase 3 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
HERPUD1 | Homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
HHATL | Hedgehog acyltransferase-like | Predicted membrane proteins
| | | | | Group enriched |
HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
IFITM1 | Interferon induced transmembrane protein 1 | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
IKZF1 | IKAROS family zinc finger 1 (Ikaros) | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
IYD | Iodotyrosine deiodinase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
JKAMP | JNK1/MAPK8-associated membrane protein | Cancer-related genes Predicted membrane proteins
| | | | | Expressed in all |
KCNJ1 | Potassium inwardly-rectifying channel, subfamily J, member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
KCNJ5 | Potassium inwardly-rectifying channel, subfamily J, member 5 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KIAA1467 | KIAA1467 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
LPCAT2 | Lysophosphatidylcholine acyltransferase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
LRRC37B | Leucine rich repeat containing 37B | Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
MIA3 | Melanoma inhibitory activity family, member 3 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
MOG | Myelin oligodendrocyte glycoprotein | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
MS4A12 | Membrane-spanning 4-domains, subfamily A, member 12 | Predicted membrane proteins
| | | | | Group enriched |
MS4A2 | Membrane-spanning 4-domains, subfamily A, member 2 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
MS4A3 | Membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
MT-CO2 | Mitochondrially encoded cytochrome c oxidase II | Disease related genes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
NPSR1 | Neuropeptide S receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
NUP210L | Nucleoporin 210kDa-like | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enriched |
P2RX6 | Purinergic receptor P2X, ligand-gated ion channel, 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
PDPN | Podoplanin | Predicted membrane proteins
| | | | | Tissue enhanced |
PEX12 | Peroxisomal biogenesis factor 12 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PEX13 | Peroxisomal biogenesis factor 13 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PIGN | Phosphatidylinositol glycan anchor biosynthesis, class N | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
PLA2G15 | Phospholipase A2, group XV | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
PLLP | Plasmolipin | Predicted membrane proteins
| | | | | Mixed |
PLP1 | Proteolipid protein 1 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
POLR1E | Polymerase (RNA) I polypeptide E, 53kDa | Predicted intracellular proteins Predicted membrane proteins RNA polymerase related proteins
| | | | | Expressed in all |
PREB | Prolactin regulatory element binding | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
PSEN1 | Presenilin 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PTPN5 | Protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
PTPRO | Protein tyrosine phosphatase, receptor type, O | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RABAC1 | Rab acceptor 1 (prenylated) | Predicted membrane proteins
| | | | | Expressed in all |
RER1 | Retention in endoplasmic reticulum sorting receptor 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
RNF186 | Ring finger protein 186 | Predicted membrane proteins
| | | | | Tissue enhanced |